Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
Georgetown University Medical Center, Washington D.C.

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06989437

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Georgetown University Medical Center, Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

MedStar Washington Hospital Center, Washington D.C.

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

MedStar Washington Hospital Center, Washington D.C.

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07174336

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06863272

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Sibley Memorial Hospital, Washington D.C.

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 18–75 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07038343

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Research Site, Washington D.C.

Vključevanje udeležencevFaza 2

Starost 18–130 · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Washington D.C.

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 29. jul. 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

George Washington University, Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT05533697

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

MedStar Washington Hospital Center, Washington D.C.

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 16. jun. 2026 · NCT05208047

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Georgetown University Medical Center, Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 27. maj 2026 · NCT05384626

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Cancer Support Community Research & Training Institute, Washington D.C.

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT02333604

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

The George Washington University, Washington D.C.

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06064877

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Washington DC VA Medical Center, Washington, DC, Washington D.C.

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Moški · Posodobljeno 8. apr. 2026 · NCT04787744

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Georgetown University Medical Center, Washington D.C.

Vključevanje udeležencevFaza 2/3

Vse starosti · Vsi spoli · Posodobljeno 2. apr. 2026 · NCT06581406

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Georgetown University Medical Center, Washington D.C.
Sibley Memorial Hospital, Washington D.C.

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 25. feb. 2026 · NCT06521554

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

The George Washington University Cancer Center (site 212), Washington D.C.

Vključevanje udeležencevFaza 1/2

Starost 18–80 · Vsi spoli · Posodobljeno 11. dec. 2025 · NCT03556228

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.